TY - JOUR
T1 - Racial disparity in short-term outcomes after gastric bypass surgery
AU - Cheung, Lily K.
AU - Lal, Lincy S.
AU - Chow, Diana S.L.
AU - Sherman, Vadim
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2013/12
Y1 - 2013/12
N2 - Background: Roux-en-Y gastric bypass procedure is the most frequently performed bariatric surgery for the extremely obese in USA. However, the information about the effects of racial/ethnic differences, comorbidities, and medication use on weight loss outcomes is limited. The objectives of this study were to investigate if race/ethnicity, comorbidities, and medication use affect weight loss effectiveness after the surgery. Methods: This is a retrospective observational study conducted at one teaching hospital at Houston metropolitan area, TX, USA. Patients between 18 and 64 years, with body mass index (BMI) of ≥40 or BMI of ≥35 with comorbidities, who had completed medical evaluations/consultations and met insurance policy requirements, were included in the study. Results: From a total of 40 patients in the study (40 % African Americans, 35 % Caucasians, 17.5 % Hispanics, 7.5 % others), the weight loss was significantly greater in Caucasian patients at 6 months after the surgery, with mean percentage excess weight loss (%EWL) of 40.6 ± 17.3, as compared to all other racial groups combined at %EWL of 30.9 ± 11.5 (p value 0.04). No association was found between the 6-month weight loss and other variables including age, gender, BMI prior to surgery, comorbidities, and total number of medications taken before the surgery. Conclusions: This study found that Caucasian patients had a significantly greater %EWL at 6 months post-op as compared to their African-American and Hispanic counterparts. No other variables exhibited significant impact on the weight loss. Further studies with a larger sample size are needed to confirm the results from this study.
AB - Background: Roux-en-Y gastric bypass procedure is the most frequently performed bariatric surgery for the extremely obese in USA. However, the information about the effects of racial/ethnic differences, comorbidities, and medication use on weight loss outcomes is limited. The objectives of this study were to investigate if race/ethnicity, comorbidities, and medication use affect weight loss effectiveness after the surgery. Methods: This is a retrospective observational study conducted at one teaching hospital at Houston metropolitan area, TX, USA. Patients between 18 and 64 years, with body mass index (BMI) of ≥40 or BMI of ≥35 with comorbidities, who had completed medical evaluations/consultations and met insurance policy requirements, were included in the study. Results: From a total of 40 patients in the study (40 % African Americans, 35 % Caucasians, 17.5 % Hispanics, 7.5 % others), the weight loss was significantly greater in Caucasian patients at 6 months after the surgery, with mean percentage excess weight loss (%EWL) of 40.6 ± 17.3, as compared to all other racial groups combined at %EWL of 30.9 ± 11.5 (p value 0.04). No association was found between the 6-month weight loss and other variables including age, gender, BMI prior to surgery, comorbidities, and total number of medications taken before the surgery. Conclusions: This study found that Caucasian patients had a significantly greater %EWL at 6 months post-op as compared to their African-American and Hispanic counterparts. No other variables exhibited significant impact on the weight loss. Further studies with a larger sample size are needed to confirm the results from this study.
KW - Comorbidities
KW - Ethnicity
KW - Gastric bypass surgery
KW - Medication use
KW - Obesity
KW - Race
KW - Weight loss
UR - http://www.scopus.com/inward/record.url?scp=84889078346&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84889078346&partnerID=8YFLogxK
U2 - 10.1007/s11695-013-1034-8
DO - 10.1007/s11695-013-1034-8
M3 - Article
C2 - 23868139
AN - SCOPUS:84889078346
SN - 0960-8923
VL - 23
SP - 2096
EP - 2103
JO - Obesity Surgery
JF - Obesity Surgery
IS - 12
ER -